CytoDyn Files CMC Of Interim Order Application To Health Canada For COVID-19 - Quick Facts

CytoDyn Inc. (CYDY.OB), a late-stage biotechnology company developing leronlimab, has submitted the manufacturing section of the application for an Interim Order to Health Canada for COVID-19 under a rolling review. This documents the company's manufacturing practices are in full compliance with GMP requirements.

CytoDyn also noted that, in Brazil, two clinical trial protocols for COVID-19 will be submitted to ANVISA, the Brazilian regulatory authority. In the U.S., the company will soon finalize a COVID-19 trial protocol to potentially include a dosage regimen utilizing IV as the first dose and three subcutaneous doses thereafter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT